Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-03

Clinical Trial Update: Atorvastatin Versus Vitamin E in Treatment of Non-alcoholic Fatty Liver Disease [Phase 4]

View source ↗

Summary

Phase 4 trial comparing atorvastatin to vitamin E for non-alcoholic fatty liver disease; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lipitor (atorvastatin)
  • Vitamin E (tocopherol)

Snippet

Sponsor: Xin Gao | Conditions: Fatty Liver, Dyslipidemias | Phase 4 | Status: UNKNOWN